Skip to main content
OpenTrials

Clinical trial condition

Somatostatin Receptor-positive GEP-NET

Explore clinical trials studying Somatostatin Receptor-positive GEP-NET. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Somatostatin Receptor-positive GEP-NET trial results

Completed

A Post Marketing Surveillance on Lutathera® in Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine Tumor in Korea

NCT04946305

Conditions
Somatostatin Receptor-positive GEP-NET
Locations
  • Novartis Investigative Site Seongnam-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Seoul, South Korea
  • Novartis Investigative Site Seoul, South Korea
  • Novartis Investigative Site Seoul, South Korea
View Trial Details